Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 4, 2017
Investors want more women, minorities on corporate boards
What do Amazon, Facebook, and Netflix have in common? Not a single person of color sits on their corporate boards. For that reason alone, the ...
August 3, 2017
Arrowhead Reports Fiscal 2017 Third Quarter Results
PASADENA, Calif.-- (BUSINESS WIRE) -- Arrowhead Pharmaceuticals, Inc. (ARWR), today announced financial results for its fiscal 2017 third quarter ended June 30, 2017. The company is ...
August 3, 2017
Achaogen Reports Second Quarter 2017 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
August 3, 2017
TherapeuticsMD Announces Second Quarter 2017 Financial Results
BOCA RATON, Fla.-- (BUSINESS WIRE) -- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced its financial results for the quarter ended June ...
August 3, 2017
Mirati Therapeutics Reports Second Quarter 2017 Financial Results
SAN DIEGO, Aug. 3, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the second quarter 2017. ...
August 3, 2017
MediWound Reports Second Quarter 2017 Financial Results
YAVNE, Israel, Aug. 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
August 3, 2017
Minerva Neurosciences Reports Second Quarter 2017 Financial Results and Business Updates
WALTHAM, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
August 3, 2017
Catalyst Biosciences Reports Second Quarter 2017 Financial Results and Provides Subcutaneous (SQ) Hemophilia Program Update
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced financial results for the second quarter ended June 30, ...
August 3, 2017
Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
REHOVOT, Israel, and BRIDGEWATER, New Jersey, Aug. 3, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
August 3, 2017
Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse® in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
WARREN, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration ...
August 3, 2017
Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts
Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that data in multiple ...
August 2, 2017
Paratek Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results and Provides Clinical Update
BOSTON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
August 2, 2017
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
LONDON, Aug. 2, 2017 /PRNewswire/ -- Based on its recent analysis of the blood purification market, Frost & Sullivan recognizes CytoSorbents Corporation with the 2017 Global ...
August 2, 2017
Sierra Oncology to Present at the 2017 Wedbush PacGrow Healthcare Conference
VANCOUVER, Aug. 2, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
August 2, 2017
VBL Therapeutics to Report Second Quarter 2017 Results on August 14
TEL AVIV, Israel, Aug. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
August 2, 2017
Lipocine to Present at the Canaccord Genuity 37th Annual Growth Conference
SALT LAKE CITY, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and ...
August 2, 2017
AgeX Therapeutics Obtains $10 Million in Capital and Commences Operations
ALAMEDA, Calif.-- (BUSINESS WIRE) -- AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE MKT: BTX), today reported that it has successfully raised $10 million ...
August 2, 2017
Advaxis to Present at Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
PRINCETON, N.J. -- (BUSINESS WIRE) -- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced three ...
August 1, 2017
VALNEVA Announces Expansion of its Management Board - Strengthening Senior Management for Future Growth
Lyon (France), August 1, 2017 - Valneva SE ("Valneva" or "the Company"), a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, ...
August 1, 2017
Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief ...
Page 122 of 138